InvestSMART

Enlitic Inc (ASX:ENL)

ALERT: Price-sensitive ASX Announcement for ENL
Current share price for ENL : $0.005 -0.024 (-82.76%)+
Announcement
Release
31 Oct 2025 9:38AM
Price at Release
$0.029
Full Release
download
Summary
Enlitic, Inc. reported on their quarterly activities for Q3 FY25 ending 30 September 2025, highlighting record quarterly cash receipts of US$2.7 million and a cash balance of US$4.4 million. The company signed 40 new client contracts, significantly increasing contract value compared to the previous quarter. Despite a slower revenue recognition, Enlitic remains on track to achieve operational cash flow break-even by the end of Q4 FY25, supported by cost-saving measures and strategic OEM partnerships. Enlitic saw reduced operating cash outflows and continues to focus on expanding its AI-enabled medical imaging solutions globally.
Key Points
  • Record quarterly cash receipts of US$2.7 million.
  • Cash balance of US$4.4 million as of 30 September 2025.
  • 40 new client contracts signed, enhancing contract value.
  • Operational cash outflows reduced to US$0.8 million due to cost-saving measures.
  • Continued focus on expanding AI-enabled medical imaging solutions.
  • Anticipates operational cash flow break-even by end of Q4 FY25.
IMPORTANT NOTE: This information is autogenerated and has not been reviewed for accuracy or completeness. You should refer to the full announcement here for further information.